BACKGROUND: African Americans (AAs) suffer the widest gaps in chronic kidney disease (CKD) outcomes compared to Caucasian Americans (CAs) and this is because of the disparities that exist in both health and healthcare. In fact, the prevalence of CKD is 3.5 times higher in AAs compared to CAs. The disparities exist at all stages of CKD. Importantly, AAs are 10 times more likely to develop hypertension-related kidney failure and 3 times more likely to progress to kidney failure compared to CAs. SUMMARY: Several factors contribute to these disparities including genetic and social determinants, late referrals, poor care coordination, medication adherence, and low recruitment in clinical trials. Key Messages: The development and implementation of CKD-related evidence-based approaches, such as clinical and social determinant assessment tools for medical interventions, more widespread outreach programs, strategies to improve medication adherence, safe and effective pharmacological treatments to control or eliminate CKD, as well as the use of health information technology, and patient-engagement programs for improved CKD outcomes may help to positively impact these disparities among AAs.
BACKGROUND: African Americans (AAs) suffer the widest gaps in chronic kidney disease (CKD) outcomes compared to Caucasian Americans (CAs) and this is because of the disparities that exist in both health and healthcare. In fact, the prevalence of CKD is 3.5 times higher in AAs compared to CAs. The disparities exist at all stages of CKD. Importantly, AAs are 10 times more likely to develop hypertension-related kidney failure and 3 times more likely to progress to kidney failure compared to CAs. SUMMARY: Several factors contribute to these disparities including genetic and social determinants, late referrals, poor care coordination, medication adherence, and low recruitment in clinical trials. Key Messages: The development and implementation of CKD-related evidence-based approaches, such as clinical and social determinant assessment tools for medical interventions, more widespread outreach programs, strategies to improve medication adherence, safe and effective pharmacological treatments to control or eliminate CKD, as well as the use of health information technology, and patient-engagement programs for improved CKD outcomes may help to positively impact these disparities among AAs.
Authors: Orlando M Gutiérrez; Afshin Parsa; Tamara Isakova; Julia J Scialla; Jing Chen; John M Flack; Lisa C Nessel; Jayanta Gupta; Keith A Bellovich; Susan Steigerwalt; James H Sondheimer; Jackson T Wright; Harold I Feldman; John W Kusek; James P Lash; Myles Wolf Journal: Clin J Am Soc Nephrol Date: 2016-02-08 Impact factor: 8.237
Authors: William E Haley; Amy L Beckrich; Judith Sayre; Rebecca McNeil; Peter Fumo; Vijaykumar M Rao; Edgar V Lerma Journal: Am J Kidney Dis Date: 2014-08-30 Impact factor: 8.860
Authors: Deidra C Crews; Raquel F Charles; Michele K Evans; Alan B Zonderman; Neil R Powe Journal: Am J Kidney Dis Date: 2010-03-06 Impact factor: 8.860
Authors: Tatiana M Davidson; John McGillicuddy; Martina Mueller; Brenda Brunner-Jackson; April Favella; Ashley Anderson; Magaly Torres; Kenneth J Ruggiero; Frank A Treiber Journal: J Pers Med Date: 2015-11-17
Authors: Robert A Phillips; Marquetta Faulkner; Jennifer Gassman; Luzmaria Jaen; John W Kusek; Keith Norris; Akinlolu Ojo Journal: J Clin Hypertens (Greenwich) Date: 2004-08 Impact factor: 3.738
Authors: Salman Ahmed; Cameron T Nutt; Nwamaka D Eneanya; Peter P Reese; Karthik Sivashanker; Michelle Morse; Thomas Sequist; Mallika L Mendu Journal: J Gen Intern Med Date: 2020-10-15 Impact factor: 5.128
Authors: Satyesh K Sinha; Susanne B Nicholas; Jung Hye Sung; Adolfo Correa; Tripathi B Rajavashisth; Keith C Norris; Jae Eun Lee Journal: Diabetes Care Date: 2019-09-11 Impact factor: 17.152
Authors: Hilda O Hounkpatin; Simon D S Fraser; Rory Honney; Gavin Dreyer; Alison Brettle; Paul J Roderick Journal: BMC Nephrol Date: 2020-06-09 Impact factor: 2.388
Authors: Keith C Norris; O Kenrik Duru; Radica Z Alicic; Kenn B Daratha; Susanne B Nicholas; Sterling M McPherson; Douglas S Bell; Jenny I Shen; Cami R Jones; Tannaz Moin; Amy D Waterman; Joshua J Neumiller; Roberto B Vargas; Alex A T Bui; Carol M Mangione; Katherine R Tuttle Journal: BMC Nephrol Date: 2019-11-20 Impact factor: 2.388